Neuberger Berman Group LLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 384 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.

Quarter-by-quarter ownership
Neuberger Berman Group LLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$7,046,104
+6.8%
184,453
+0.8%
0.01%0.0%
Q2 2023$6,597,599
+22.2%
182,911
+29.4%
0.01%
+20.0%
Q1 2023$5,397,049
-29.4%
141,321
+5.1%
0.01%
-28.6%
Q4 2022$7,648,043
+8.5%
134,412
-24.6%
0.01%0.0%
Q3 2022$7,049,000
-8.6%
178,261
+1.7%
0.01%
-12.5%
Q2 2022$7,716,000
+16.4%
175,354
+5.5%
0.01%
+33.3%
Q1 2022$6,631,000
+4.5%
166,275
+4.3%
0.01%
+20.0%
Q4 2021$6,346,000
-1.1%
159,421
-0.3%
0.01%
-16.7%
Q3 2021$6,416,000
-38.8%
159,859
-30.8%
0.01%
-33.3%
Q2 2021$10,480,000
+17.9%
231,062
+8.4%
0.01%
+12.5%
Q1 2021$8,886,000
+39.9%
213,155
+43.3%
0.01%
+14.3%
Q4 2020$6,353,000
+64.8%
148,756
+1.4%
0.01%
+40.0%
Q3 2020$3,856,000
+27.6%
146,750
+30.2%
0.01%
+25.0%
Q2 2020$3,022,000
+110.6%
112,750
+41.4%
0.00%
+100.0%
Q1 2020$1,435,000
+77.2%
79,750
+99.4%
0.00%
+100.0%
Q4 2017$810,000
+831.0%
40,000
+263.6%
0.00%
Q2 2013$87,00011,0000.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Third Security, LLC 19,305,403$233,209,00010.86%
BB BIOTECH AG 7,379,832$89,148,0003.13%
SENZAR ASSET MANAGEMENT, LLC 550,544$6,650,572,0001.72%
SNYDER CAPITAL MANAGEMENT L P 2,232,114$26,964,0001.69%
Sterling Global Strategies LLC 22,000$266,0000.98%
IRIDIAN ASSET MANAGEMENT LLC/CT 9,290,024$112,223,0000.98%
MSD Partners, L.P. 965,000$11,657,0000.94%
DOHENY ASSET MANAGEMENT /CA 130,950$1,582,0000.81%
Taylor Wealth Management Partners 128,110$1,548,0000.69%
Bellevue Group AG 318,000$3,841,0000.69%
View complete list of HALOZYME THERAPEUTICS INC shareholders